392 A phase 1a/b study of IK-175, an oral AHR inhibitor, alone and in combination with nivolumab in patients with locally dvanced or metastatic solid tumors and urothelial carcinom... oleh Jason Luke, Meredith McKean, Nehal Lakhani, Katherine Kacena, Alan Tan, Babar Bashir, David Aggen, Marissa Timothy, Sergio Santillana